• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Dynavax Technologies Corp

+ Add to Watchlist

DVAX:US

1.5400 USD 0.0200 1.32%

As of 20:10:00 ET on 07/11/2014.

Company Profile for Dynavax Technologies Corp (DVAX)

Dynavax Technologies Corporation discovers, develops, and is seeking to commercialize products based on immunostimulatory sequences. The Company is developing products to treat and prevent allergies, infectious diseases, and chronic inflammatory diseases using approaches that alter immune system responses in specific ways.

Contact Information

Dynavax Technologies Corp

2929 Seventh Street
Suite 100
Berkeley, CA 94710-2753
United States
Phone: 1-510-848-5100
Fax: 1-510-450-7740

Key Executives for Dynavax Technologies Corp (DVAX)

Eddie GrayChief Executive OfficerRobert Lee CoffmanSenior VP/Chief Scientific
David L JohnsonVP/Chief Acctg OfficerMichael S OstrachVP/Chief Bus Ofcr/Secy/Gen Cnsl
Robert JanssenVP:Clinical Dev/Chief Medical OfcrDavid NovackVP:Ops & Quality

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil